Abstract
BackgroundImmune checkpoint inhibitor therapy has become an effective treatment option for many types of cancers. By enhancing the function of anti-tumor T cells, inhibitors targeting PD1, PDL1, and CTLA4 have...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
